
Anna Pagonakis
Examiner (ID: 6985)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 4173, 1609, 1628, OPET |
| Total Applications | 1238 |
| Issued Applications | 444 |
| Pending Applications | 73 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9464144
[patent_doc_number] => 20140128571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 14/147990
[patent_app_country] => US
[patent_app_date] => 2014-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47088
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14147990
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/147990 | AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS | Jan 5, 2014 | Abandoned |
Array
(
[id] => 9561954
[patent_doc_number] => 20140179667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'ARYL AND HETEROARYL FUSED LACTAMS'
[patent_app_type] => utility
[patent_app_number] => 14/132567
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104955
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14132567
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/132567 | Aryl and heteroaryl fused lactams | Dec 17, 2013 | Issued |
Array
(
[id] => 10540652
[patent_doc_number] => 09265754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-23
[patent_title] => 'Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with rett syndrome'
[patent_app_type] => utility
[patent_app_number] => 14/097623
[patent_app_country] => US
[patent_app_date] => 2013-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 6794
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14097623
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/097623 | Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with rett syndrome | Dec 4, 2013 | Issued |
Array
(
[id] => 10405224
[patent_doc_number] => 20150290233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'METHODS OF PREVENTING TUMOR METASTASIS, TREATING AND PROGNOSING CANCER AND IDENTIFYING AGENTS WHICH ARE PUTATIVE METASTASIS INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/432520
[patent_app_country] => US
[patent_app_date] => 2013-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 28123
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432520
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/432520 | METHODS OF PREVENTING TUMOR METASTASIS, TREATING AND PROGNOSING CANCER AND IDENTIFYING AGENTS WHICH ARE PUTATIVE METASTASIS INHIBITORS | Nov 27, 2013 | Abandoned |
Array
(
[id] => 9384641
[patent_doc_number] => 20140088123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'TREATMENT OF LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/091861
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9687
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091861
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/091861 | TREATMENT OF LUNG CANCER | Nov 26, 2013 | Abandoned |
Array
(
[id] => 9538343
[patent_doc_number] => 20140162991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'TESTOSTERONE-ANASTROZOLE (T + A) COMBINATION IMPLANTS IN THE NEO-ADJUVANT, LOCAL AND SYSTEMIC THERAPY OF NEWLY DIAGNOSED, PREVIOUSLY UNTREATED BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/090443
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4494
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14090443
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/090443 | TESTOSTERONE-ANASTROZOLE (T + A) COMBINATION IMPLANTS IN THE NEO-ADJUVANT, LOCAL AND SYSTEMIC THERAPY OF NEWLY DIAGNOSED, PREVIOUSLY UNTREATED BREAST CANCER | Nov 25, 2013 | Abandoned |
Array
(
[id] => 9944272
[patent_doc_number] => 08993573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => '2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/089946
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 21628
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14089946
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/089946 | 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors | Nov 25, 2013 | Issued |
Array
(
[id] => 11857882
[patent_doc_number] => 09737549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Formulations of deoxycholic acid and salts thereof'
[patent_app_type] => utility
[patent_app_number] => 14/091109
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7600
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091109
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/091109 | Formulations of deoxycholic acid and salts thereof | Nov 25, 2013 | Issued |
Array
(
[id] => 9511950
[patent_doc_number] => 20140148443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'Novel Imidazolines as dual inhibitors of MDM2 and MDMX'
[patent_app_type] => utility
[patent_app_number] => 14/084681
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18924
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084681
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/084681 | Novel Imidazolines as dual inhibitors of MDM2 and MDMX | Nov 19, 2013 | Abandoned |
Array
(
[id] => 9370915
[patent_doc_number] => 20140080789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'Method of Treating Diabetes, Glucose Intolerance, Insulin Resistance and/or Diabetes-Induced Diastolic Dysfunction'
[patent_app_type] => utility
[patent_app_number] => 14/083841
[patent_app_country] => US
[patent_app_date] => 2013-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8748
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14083841
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/083841 | Method of Treating Diabetes, Glucose Intolerance, Insulin Resistance and/or Diabetes-Induced Diastolic Dysfunction | Nov 18, 2013 | Abandoned |
Array
(
[id] => 11828744
[patent_doc_number] => 09725477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Platinum compounds of malonic acid derivative having leaving group containing amino or alkylamino'
[patent_app_type] => utility
[patent_app_number] => 14/762145
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30621
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14762145
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/762145 | Platinum compounds of malonic acid derivative having leaving group containing amino or alkylamino | Nov 14, 2013 | Issued |
Array
(
[id] => 10387916
[patent_doc_number] => 20150272922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'Compounds for Reducing Glucocorticoids, and Methods of Treatment Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/441620
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 25200
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441620
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/441620 | Compounds for Reducing Glucocorticoids, and Methods of Treatment Thereof | Nov 7, 2013 | Abandoned |
Array
(
[id] => 9363705
[patent_doc_number] => 20140073579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'SMAC Mimetic'
[patent_app_type] => utility
[patent_app_number] => 14/075190
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18501
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075190
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/075190 | SMAC mimetic for treating myelodysplastic syndromes | Nov 7, 2013 | Issued |
Array
(
[id] => 9363762
[patent_doc_number] => 20140073635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'Substituted Imidazopyridinyl-Aminopyridine Compounds'
[patent_app_type] => utility
[patent_app_number] => 14/075505
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57508
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075505
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/075505 | Substituted imidazopyridinyl-aminopyridine compounds | Nov 7, 2013 | Issued |
Array
(
[id] => 11783943
[patent_doc_number] => 09393216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-19
[patent_title] => 'Vaginal matrices: nanofibers for contraception and prevention of HIV infection'
[patent_app_type] => utility
[patent_app_number] => 14/073734
[patent_app_country] => US
[patent_app_date] => 2013-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 39
[patent_no_of_words] => 36788
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073734
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/073734 | Vaginal matrices: nanofibers for contraception and prevention of HIV infection | Nov 5, 2013 | Issued |
Array
(
[id] => 9338464
[patent_doc_number] => 20140065246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'INTRACELLULAR CALCIUM MODULATION FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/073850
[patent_app_country] => US
[patent_app_date] => 2013-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7510
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073850
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/073850 | INTRACELLULAR CALCIUM MODULATION FOR CANCER TREATMENT | Nov 5, 2013 | Abandoned |
Array
(
[id] => 9462758
[patent_doc_number] => 20140127185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'METHODS AND COMPOSITIONS USING NEUROPROTECTIVE STEROIDS AND THROMBOLYTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/068475
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12213
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14068475
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/068475 | METHODS AND COMPOSITIONS USING NEUROPROTECTIVE STEROIDS AND THROMBOLYTIC AGENTS | Oct 30, 2013 | Abandoned |
Array
(
[id] => 9331115
[patent_doc_number] => 20140057897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'METHOD OF TREATING MIXED LINEAGE LEUKEMIA GENE-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIAS'
[patent_app_type] => utility
[patent_app_number] => 14/068017
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1371
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14068017
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/068017 | METHOD OF TREATING MIXED LINEAGE LEUKEMIA GENE-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIAS | Oct 30, 2013 | Abandoned |
Array
(
[id] => 10114661
[patent_doc_number] => 09149525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'Delivery of corticosteroids through iontophoresis'
[patent_app_type] => utility
[patent_app_number] => 14/060055
[patent_app_country] => US
[patent_app_date] => 2013-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9328
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14060055
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/060055 | Delivery of corticosteroids through iontophoresis | Oct 21, 2013 | Issued |
Array
(
[id] => 9422439
[patent_doc_number] => 20140107090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'TREATMENT AND PREVENTION OF MASTITIS'
[patent_app_type] => utility
[patent_app_number] => 14/056122
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20110
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14056122
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/056122 | Treatment and prevention of mastitis | Oct 16, 2013 | Issued |